share_log
Reuters ·  Mar 26 20:05
Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of Rt-114, a GLP-1/Glp-2 Dual Agonist (Pg-102) Delivered Orally via the Ranipill® Capsule, to Subcutaneously Administered Pg-102
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 281

Recommended

Write a comment